Cita APA

Rosar, F., Krause, J., Bartholomä, M., Maus, S., Stemler, T., Hierlmeier, I., . . . Khreish, F. (2021). Efficacy and Safety of [(225)Ac]Ac-PSMA-617 Augmented [(177)Lu]Lu-PSMA-617 Radioligand Therapy in Patients with Highly Advanced mCRPC with Poor Prognosis. Pharmaceutics.

Citación estilo Chicago

Rosar, Florian, Jonas Krause, Mark Bartholomä, Stephan Maus, Tobias Stemler, Ina Hierlmeier, Johannes Linxweiler, Samer Ezziddin, y Fadi Khreish. "Efficacy and Safety of [(225)Ac]Ac-PSMA-617 Augmented [(177)Lu]Lu-PSMA-617 Radioligand Therapy in Patients With Highly Advanced MCRPC With Poor Prognosis." Pharmaceutics 2021.

Cita MLA

Rosar, Florian, et al. "Efficacy and Safety of [(225)Ac]Ac-PSMA-617 Augmented [(177)Lu]Lu-PSMA-617 Radioligand Therapy in Patients With Highly Advanced MCRPC With Poor Prognosis." Pharmaceutics 2021.